Directory

>

Andrew Schiermeier

Andrew Schiermeier

Chief Executive Officer | AvenCell

Cambridge, Massachusetts, United States

View contact details (it's free)

Andrew Schiermeier

Summary

Andrew Schiermeier is an accomplished executive with extensive experience in the biopharmaceutical and biotechnology sectors, currently serving as the President and CEO of AvenCell Therapeutics, Inc. His career spans over two decades, during which he has held various leadership roles in notable organizations such as Intellia Therapeutics and Merck Kgaa Darmstadt. With a strong academic background, including a Ph.D. from Harvard University, Andrew specializes in drug development, clinical trials, and oncology. He has a proven track record of driving innovation and strategy in both startups and established companies. His passion for advancing medical therapies reflects a commitment to improving patient outcomes through engineered cell therapies. Andrew's leadership style emphasizes cross-functional collaboration and strategic vision, making him a respected figure in the life sciences community.

General

Generalist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Andrew Schiermeier

Work Experience

company logo

Chief Executive Officer at

AvenCell

August 2021 - Present

company logo

Chief Operating Officer at

Intellia Therapeutics, Inc.

July 2019 - August 2021

company logo

Executive Vice President, Head of Corporate Strategy & Development (Interim Head of Research) at

Intellia Therapeutics, Inc.

October 2018 - August 2021

company logo

Executive Vice President, Corporate Strategy at

Intellia Therapeutics, Inc.

April 2018 - October 2018

company logo

Senior Vice President, eXtellia at

Intellia Therapeutics, Inc.

January 2017 - April 2018

company logo

SVP, Global Head of Oncology & GM of Pfizer/Merck ImmunoOncology Alliance at

Merck KGaA, Darmstadt, Germany

May 2013 - January 2016

company logo

Chairman (former CEO) at

Medicine In Need

November 2007 - December 2014

company logo

Corporate Advisor at

Pathogenica

January 2012 - May 2013

company logo

Chief Operating Officer at

Aura Biosciences

January 2011 - May 2013

company logo

CEO at

Lantibio

February 2007 - January 2008

💼

Vice President at

Paramount BioSciences

January 2006 - January 2008

company logo

Senior Manager at

EY

January 2005 - January 2006

company logo

Senior Engagement Manager at

Strategic Decisions Group (SDG)

January 1996 - January 2004

company logo

Senior Director at

Aventis Pharma

January 1999 - January 2002

Logos provided by Logo.dev

Andrew Schiermeier

Education

Harvard University, Ph.D.

January 1992 - January 1997

College des Ingenieurs, Mba

January 1996 - January 1997

Stanford University, M.S.

January 1991 - January 1992

University of Cambridge, B.S.

January 1988 - January 1991

Washington University in St. Louis, Bs

January 1987 - January 1991

Frequently Asked Questions about Andrew Schiermeier

What is Andrew Schiermeier email address?

Andrew Schiermeier's primary email address is ******************@emdgroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Andrew Schiermeier work for?

Andrew Schiermeier is a Chief Executive Officer at AvenCell.

Where Andrew Schiermeier graduated from?

Andrew Schiermeier holds a degree in Engineering & Applied Math from Harvard University.

How can I directly contact Andrew Schiermeier?

To contact Andrew Schiermeier directly, you can use the email address ******************@emdgroup.com. Complete contact information is available upon registration with Muraena.

Who is Andrew Schiermeier?

Andrew Schiermeier is an accomplished executive with extensive experience in the biopharmaceutical and biotechnology sectors, currently serving as the President and CEO of AvenCell Therapeutics, Inc. His career spans over two decades, during which he has held various leadership roles in notable organizations such as Intellia Therapeutics and Merck Kgaa Darmstadt. With a strong academic background, including a Ph.D. from Harvard University, Andrew specializes in drug development, clinical trials, and oncology. He has a proven track record of driving innovation and strategy in both startups and established companies. His passion for advancing medical therapies reflects a commitment to improving patient outcomes through engineered cell therapies. Andrew's leadership style emphasizes cross-functional collaboration and strategic vision, making him a respected figure in the life sciences community.

Andrew`s contact details

mail

******************@emdgroup.com

******************@intelliatx.com

******************@avencell.com

Colleagues

avatar
Paris Panayiotopoulos

Founder, Board Director

avatar
Susan Buttler

Vice President Clinical Operations

avatar
Reynald Lescarbeau

VP, Head of US Research

View Contact details (it's free)
Request Profile Removal